{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:59:44Z","timestamp":1790092784728,"version":"4.0.1"},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:p>This JAMA Clinical Guidelines Synopsis summarizes the American College of Gastroenterology\u2019s (ACG) 2025 clinical guideline update on management of ulcerative colitis in adults.<\/jats:p>","DOI":"10.1001\/jama.2026.8803","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:30:29Z","timestamp":1784734229000},"page":"1061","source":"Crossref","is-referenced-by-count":0,"title":["Ulcerative Colitis Management in Adults"],"prefix":"10.1001","volume":"336","author":[{"given":"Lauren P.","family":"Loeb","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jami A.","family":"Kinnucan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"jgs260011r1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: a review.","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"jgs260011r2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1053\/j.gastro.2024.10.001","article-title":"AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis.","volume":"167","author":"Singh","year":"2024","journal-title":"Gastroenterology"},{"issue":"6","key":"jgs260011r3","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","article-title":"ACG clinical guideline update: ulcerative colitis in adults.","volume":"120","author":"Rubin","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"jgs260011r4","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD).","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"jgs260011r5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004115.pub2","article-title":"Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.","author":"Marshall","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"jgs260011r6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/ecco-jcc\/jjad004","article-title":"Rescue therapies for steroid-refractory acute severe ulcerative colitis.","volume":"17","author":"Gisbert","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"13","key":"jgs260011r7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","article-title":"Vedolizumab vs adalimumab for moderate-to-severe ulcerative colitis.","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"jgs260011r8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40265-023-01840-5","article-title":"Safety of Janus kinase inhibitors in inflammatory bowel diseases.","volume":"83","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Drugs"},{"issue":"2","key":"jgs260011r9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(21)00377-0","article-title":"Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis.","volume":"7","author":"Lasa","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2851958\/jama_loeb_2026_gs_260011_1789422123.57496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:02:02Z","timestamp":1790089322000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2851958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.8803","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}